Controlled Release of Bevacizumab Through Nanospheres for Extended Treatment of Age-Related Macular Degeneration

Overview of attention for article published in Open Ophthalmology Journal, June 2012

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#23 of 111)
Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 125 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Delivery compositions, and methods of making and using same

Grant US-11484505-B2

United States of America

Albumin nanoparticles for the treatment of cancer and ocular diseases

Grant US-10993994-B2

United States of America

Loteprednol etabonate nanoparticles in thermoreversible gels for enhanced therapeutics

Grant US-10973776-B1

United States of America

Nanoparticles in thermoreversible gels for enhanced therapeutics

Grant US-10729663-B1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.